The functional contribution of PD-L1 on tumor cells versus host APCs in engaging PD-1 on TILs and inhibiting T cell function has been controversial but likely varies with the tumor model or cancer histology being studied, and also the degree of antigenicity. The gene discussed is CD274; the disease is cancer.